X
OCGN icon

Xponance’s Ocugen OCGN Stock Holding History

Xponance’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,951
Closed -$13.4K – 1532
2025
Q1 		$13.4K Buy
18,951
+489
+3% +$338 ﹤0.01% 1436
2024
Q4 		$14.9K Buy
18,462
+1,711
+10% +$1.57K ﹤0.01% 1437
2024
Q3 		$16.6K Buy
16,751
+890
+6% +$1.22K ﹤0.01% 1383
2024
Q2 		$24.6K Buy
+15,861
New +$24.7K ﹤0.01% 1302
2023
Q2 		– Sell
-12,360
Closed -$10.5K – 1281
2023
Q1 		$10.5K Hold
12,360
– – ﹤0.01% 1230
2022
Q4 		$16.1K Buy
12,360
+382
+3% +$595 ﹤0.01% 1220
2022
Q3 		$21K Buy
11,978
+452
+4% +$1.13K ﹤0.01% 1180
2022
Q2 		$26K Buy
+11,526
New +$27.6K ﹤0.01% 1173
2021
Q3 		– Sell
-10,111
Closed -$81K – 1214
2021
Q2 		$81K Buy
+10,111
New +$85.3K ﹤0.01% 1219

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Xponance's OCGN Position: Q2 2025 in Review

Xponance sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 18,951 shares — an estimated $13.4K sold.

Xponance first reported a position in OCGN in Q2 2021 and held it in 9 quarters. The position peaked at $81K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • Xponance reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • Xponance sold 18,951 Ocugen shares in Q2 2025, an estimated $13.4K.
  • Xponance first reported a position in Ocugen in Q2 2021 and held it in 9 quarters.
  • Xponance's Ocugen position peaked at $81K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on Xponance's 13F filing for Q2 2025, filed 14 Aug 2025.